Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cann Group ( (AU:CAN) ) has issued an announcement.
Cann Group Limited has notified the market of the issue of a substantial tranche of unquoted options, with a total of 93,163,266 options being created across two new classes, both expiring on 24 December 2027 and carrying exercise prices of $0.0230 and $0.0146 respectively. The options, which are not intended to be quoted on the ASX, form part of previously disclosed transactions and signal ongoing use of equity-linked incentives or financing structures that could, if exercised, increase the company’s share base and potentially provide additional capital, with implications for existing shareholders’ dilution and the company’s long-term funding strategy.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited is an Australian-listed company (ASX: CAN) operating in the medicinal cannabis sector, focused on the cultivation, manufacture and supply of cannabis-based products for domestic and international markets. The company develops pharmaceutical-grade cannabis formulations and aims to service both medical and potentially broader therapeutic markets as regulatory frameworks evolve.
Average Trading Volume: 5,287,410
Technical Sentiment Signal: Sell
Current Market Cap: A$14M
See more data about CAN stock on TipRanks’ Stock Analysis page.